International Archives of Allergy and Immunology
Overview
The International Archives of Allergy and Immunology is a peer-reviewed journal that publishes cutting-edge research in the field of allergy and immunology. It covers a wide range of topics including allergic diseases, immunodeficiencies, asthma, autoimmune disorders, and immunotherapy. The journal aims to advance knowledge and understanding of these conditions through high-quality scientific articles, reviews, and case reports.
Details
Details
Abbr.
Int Arch Allergy Immunol
Start
1992
End
Continuing
Frequency
Monthly
p-ISSN
1018-2438
e-ISSN
1423-0097
Country
Switzerland
Language
English
Specialty
Allergy & Immunology
Metrics
Metrics
h-index / Ranks: 2538
112
SJR / Ranks: 6911
650
CiteScore / Ranks: 3928
5.90
JIF / Ranks: 3791
2.8
Recent Articles
1.
Li S, Pu X, Zhou J, Wang C, Wang J, Kulaixi X, et al.
Int Arch Allergy Immunol
. 2025 Mar;
:1-12.
PMID: 40073853
Objective: This study aimed to investigate the role of Raf kinase inhibitor protein (RKIP) in degranulation induced by echinococcal cyst fluid (EgCF) in bone marrow-derived mast cells (BMMCs). Methods: Primary...
2.
Tuzer C, Yegit O, Sonmez N, Ertek B, Demirpek U, Demir S, et al.
Int Arch Allergy Immunol
. 2025 Mar;
:1-21.
PMID: 40068650
Background: The role of Blastocystis spp. subtypes (STs) in chronic spontaneous urticaria (CSU) and the impact of the eradication are unclear. Objective: To investigate the role of Blastocystis spp. STs...
3.
Fu S, Wei Y, Liu D, Yuan J, Yi J, Hu X, et al.
Int Arch Allergy Immunol
. 2025 Mar;
:1-18.
PMID: 40058348
Introduction: Nasal inverted papilloma (NIP) is a common nasal benign tumor, with a complex pathogenesis closely linked to inflammatory response. It can be classified into Grade-I and Grade-II phenotypes based...
4.
Colli L, Yu J, Lanoue D, Mir A, Cohen C, Toscano-Rivero D, et al.
Int Arch Allergy Immunol
. 2025 Mar;
:1-17.
PMID: 40043695
Introduction: Oral food challenges are the gold standard for diagnosis and reactivity thresholds but are resource-intensive and high-risk for reactions. Limited data on factors associated with increased risk of positive...
5.
Koken G, Polat Terece S, Varer Akpinar C, Ertoy Karagol H, Bakirtas A
Int Arch Allergy Immunol
. 2025 Mar;
:1-11.
PMID: 40037316
Introduction: So far, there is no direct comparison between inhaled corticosteroids (ICS) monotherapy and ICS-long acting beta-2 agonists (LABA) fixed-dose combination therapies in 6-11-year-old children with persistent asthma. The primary...
6.
Kayikci H, Damadoglu E, Cihanbeylerden M, Tuccar C, Pehlivanlar Ustaoglu A, Karakaya G, et al.
Int Arch Allergy Immunol
. 2025 Mar;
:1-12.
PMID: 40024246
Introduction: Surgical interventions can trigger angioedema attacks in hereditary angioedema (HAE). The aim of this study was to assess the incidence of perioperative angioedema and identify associated risk factors. Methods:...
7.
Zhao X, Li M, Zhang X, Tian Y, Li D, Wang Y, et al.
Int Arch Allergy Immunol
. 2025 Feb;
:1-18.
PMID: 40010328
Objective: The aim of this study was to compare the clinical efficacy and safety of interleukin-17 inhibitors and Janus kinase inhibitors in the treatment of ankylosing spondylitis based on a...
8.
Jia Y, Tu J, Tang B, Jiang F, Luo Q, Ye J
Int Arch Allergy Immunol
. 2025 Feb;
:1-24.
PMID: 40010321
Introduction Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) is a widespread inflammatory disease, classified into Eosinophilic (EosCRSwNP) and non-Eosinophilic (non-EosCRSwNP) types. Nitric oxide (NO) plays a role in pathophysiological processes, with...
9.
Zhao Y, Huang H, Zou H, Qian Y, Wang X, Guan W, et al.
Int Arch Allergy Immunol
. 2025 Feb;
:1-25.
PMID: 40010311
Objective: To observe and assess the efficacy and safety of Artemisia annua (A. annua)-sublingual immunotherapy (SLIT) in patients with mild-moderate allergic asthma (AS). Methods: In this retrospective study, the complete...
10.
Yang Q, Sun Y, An J, Wang L, Zhang C, Fei Y, et al.
Int Arch Allergy Immunol
. 2025 Feb;
:1-19.
PMID: 40010305
Background: Allergic rhinitis (AR) is a systemic immune inflammatory response disease of the nasal mucosa. Current treatment strategies for AR are limited owing to a lack of safety and the...